Top Page
Cross Country Healthcare
(NASDAQ:CCRN)
Cross Country Healthcare (CCRN) vs. SPDR S&P 500 ETF (SPY)
Cross Country Healthcare Business Overview & Revenue Model
Cross Country Healthcare Earnings Call Summary
Cross Country Healthcare Financial Statement Overview
| Breakdown |
|---|
Income Statement |
| Total Revenue |
| Gross Profit |
| EBITDA |
| Net Income |
Balance Sheet |
| Total Assets |
| Cash, Cash Equivalents and Short-Term Investments |
| Total Debt |
| Total Liabilities |
| Stockholders Equity |
Cash Flow |
| Free Cash Flow |
| Operating Cash Flow |
| Investing Cash Flow |
| Financing Cash Flow |
Cross Country Healthcare Technical Analysis
Cross Country Healthcare Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | ― | ― | ― | ― | ― | ― | |
62 Neutral | $1.14B | 119.68 | 1.29% | ― | 68.17% | -85.42% | |
61 Neutral | $444.65M | 1.32 | ― | ― | 0.74% | ― | |
57 Neutral | $818.21M | -2.96 | -35.90% | ― | -11.42% | -617.31% | |
57 Neutral | $753.03M | -43.02 | -6.86% | ― | 12.48% | -9.28% | |
48 Neutral | $305.32M | -19.30 | -3.76% | ― | -22.14% | -787.87% | |
46 Neutral | $345.01M | -1.07 | -73.31% | ― | 5.21% | 5.21% |
Cross Country Healthcare Corporate Events
Cross Country Healthcare, Inc.’s board of directors scheduled the company’s 2026 Annual Meeting of Stockholders as a virtual-only event to be held on May 11, 2026, moving it more than 30 days earlier than the anticipated anniversary date of the 2025 annual meeting. Because of this change in timing, the company revised the deadlines for stockholder actions: proposals for inclusion in the proxy statement under SEC Rule 14a-8 must be received at its Boca Raton, Florida headquarters by the close of business on March 11, 2026; advance-notice proposals of business or board nominees under the company’s bylaws must be delivered by February 10, 2026; and stockholders intending to solicit proxies for alternative director nominees under the universal proxy rules must provide the required notice by March 12, 2026, ensuring investors and activists have clear timelines for influencing governance and board composition at the 2026 meeting.
The most recent analyst rating on (CCRN) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
On December 15, 2025, Cross Country Healthcare announced the departure of John A. Martins as President and CEO, effective December 14, 2025. Kevin C. Clark, the company’s co-founder and current Chairman, has been appointed as the new President and CEO. This leadership change is seen as a strategic move to usher in a new era of growth and innovation, particularly following the termination of a transaction with Aya Healthcare. Clark’s extensive experience in the healthcare staffing industry is expected to drive the company towards sustainable, long-term profitable growth.
The most recent analyst rating on (CCRN) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
On December 9, 2025, Cross Country Healthcare held its Annual Meeting of Stockholders where several key proposals were voted on. The stockholders approved the election of directors for a one-year term, ratified the appointment of Deloitte & Touche as the independent registered public accounting firm for the fiscal year ending December 31, 2025, and approved the compensation of named executive officers on an advisory basis.
The most recent analyst rating on (CCRN) stock is a Hold with a $9.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
On December 4, 2025, Cross Country Healthcare announced the termination of its merger agreement with Aya Holdings II Inc. due to the failure to meet the merger’s consummation deadline, partly caused by an extended FTC review period. As a result, Aya Healthcare will pay a $20 million termination fee to Cross Country Healthcare. Despite the setback, Cross Country Healthcare remains focused on its strategic goals, emphasizing its operational resilience and financial strength, and plans to commence share repurchases under its existing $40 million authorization.
The most recent analyst rating on (CCRN) stock is a Hold with a $10.50 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.
Cross Country Healthcare announced its financial results for the third quarter of 2025, revealing a consolidated revenue of $250.1 million, a 21% decrease year-over-year. Despite a net loss of $4.8 million, the company reported strong performance in its Homecare Staffing segment, with a 29% revenue growth over the prior year. The company maintained a healthy balance sheet with $99 million in cash and no debt, and positive cash flow from operations of $20 million for the quarter. As the company awaits the completion of its merger with Aya Healthcare, it continues to focus on expanding and renewing contracts, with over $400 million in contract value secured.
The most recent analyst rating on (CCRN) stock is a Hold with a $13.00 price target. To see the full list of analyst forecasts on Cross Country Healthcare stock, see the CCRN Stock Forecast page.